PDB Short entry for 4OBO HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-JAN-14 4OBO TITLE MAP4K4 IN COMPLEX WITH INHIBITOR (COMPOUND 22), 6-(3-CHLOROPHENYL) TITLE 2 QUINAZOLIN-4-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: HPK/GCK-LIKE KINASE HGK, MAPK/ERK KINASE KINASE KINASE 4, COMPND 6 MEK KINASE KINASE 4, MEKKK 4, NCK-INTERACTING KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HGK, KIAA0687, MAP4K4, NIK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.F.HARRIS,P.WU,M.COONS REVDAT 4 28-FEB-24 4OBO 1 REMARK SEQADV LINK REVDAT 3 22-NOV-17 4OBO 1 REMARK REVDAT 2 07-MAY-14 4OBO 1 JRNL REVDAT 1 23-APR-14 4OBO 0 JRNL AUTH T.D.CRAWFORD,C.O.NDUBAKU,H.CHEN,J.W.BOGGS,B.J.BRAVO, JRNL AUTH 2 K.DELATORRE,A.M.GIANNETTI,S.E.GOULD,S.F.HARRIS,S.R.MAGNUSON, JRNL AUTH 3 E.MCNAMARA,L.J.MURRAY,J.NONOMIYA,A.SAMBRONE,S.SCHMIDT, JRNL AUTH 4 T.SMYCZEK,M.STANLEY,P.VITORINO,L.WANG,K.WEST,P.WU,W.YE JRNL TITL DISCOVERY OF SELECTIVE 4-AMINO-PYRIDOPYRIMIDINE INHIBITORS JRNL TITL 2 OF MAP4K4 USING FRAGMENT-BASED LEAD IDENTIFICATION AND JRNL TITL 3 OPTIMIZATION. JRNL REF J.MED.CHEM. V. 57 3484 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24673130 JRNL DOI 10.1021/JM500155B REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 36153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1804 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.16 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.47 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2817 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2372 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2689 REMARK 3 BIN R VALUE (WORKING SET) : 0.2356 REMARK 3 BIN FREE R VALUE : 0.2725 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.54 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 128 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4623 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.85530 REMARK 3 B22 (A**2) : 1.25360 REMARK 3 B33 (A**2) : -8.10890 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.289 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.239 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4775 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6453 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1691 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 121 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 681 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4775 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 611 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5652 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.01 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.49 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OBO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084289. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36271 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.55500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER 2.1.4 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM CITRATE PH 8.3, 20% REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.64800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.82550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.64800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.82550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 ALA A 2 REMARK 465 ASN A 3 REMARK 465 ASP A 4 REMARK 465 SER A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 LYS A 8 REMARK 465 SER A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 ASP A 12 REMARK 465 ILE A 13 REMARK 465 ASP A 14 REMARK 465 LEU A 15 REMARK 465 GLU A 60 REMARK 465 ASP A 61 REMARK 465 GLU A 62 REMARK 465 GLU A 63 REMARK 465 GLU A 64 REMARK 465 PRO A 94 REMARK 465 PRO A 95 REMARK 465 GLY A 96 REMARK 465 HIS A 97 REMARK 465 VAL A 174 REMARK 465 SER A 175 REMARK 465 ALA A 176 REMARK 465 GLN A 177 REMARK 465 LEU A 178 REMARK 465 ASP A 179 REMARK 465 ARG A 180 REMARK 465 THR A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ARG A 184 REMARK 465 LYS A 311 REMARK 465 LYS A 312 REMARK 465 ARG A 313 REMARK 465 GLY A 314 REMARK 465 GLU A 315 REMARK 465 LYS A 316 REMARK 465 ASP A 317 REMARK 465 GLU A 318 REMARK 465 THR A 319 REMARK 465 GLU A 320 REMARK 465 TYR A 321 REMARK 465 GLU A 322 REMARK 465 TYR A 323 REMARK 465 SER A 324 REMARK 465 GLY A 325 REMARK 465 SER A 326 REMARK 465 GLU A 327 REMARK 465 GLU A 328 REMARK 465 GLY A 329 REMARK 465 ASN A 330 REMARK 465 SER A 331 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 ASP B 4 REMARK 465 SER B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 LYS B 8 REMARK 465 SER B 9 REMARK 465 LEU B 10 REMARK 465 VAL B 11 REMARK 465 GLY B 34 REMARK 465 THR B 35 REMARK 465 TYR B 36 REMARK 465 LYS B 312 REMARK 465 ARG B 313 REMARK 465 GLY B 314 REMARK 465 GLU B 315 REMARK 465 LYS B 316 REMARK 465 ASP B 317 REMARK 465 GLU B 318 REMARK 465 THR B 319 REMARK 465 GLU B 320 REMARK 465 TYR B 321 REMARK 465 GLU B 322 REMARK 465 TYR B 323 REMARK 465 SER B 324 REMARK 465 GLY B 325 REMARK 465 SER B 326 REMARK 465 GLU B 327 REMARK 465 GLU B 328 REMARK 465 GLY B 329 REMARK 465 ASN B 330 REMARK 465 SER B 331 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 28 -60.10 -103.27 REMARK 500 ASN A 33 -4.49 70.61 REMARK 500 ARG A 152 -12.30 76.54 REMARK 500 ASP A 153 51.22 -140.72 REMARK 500 ASP A 171 57.21 72.65 REMARK 500 LEU A 270 37.88 -95.84 REMARK 500 ARG B 152 -10.82 76.13 REMARK 500 ASP B 153 51.48 -141.70 REMARK 500 ARG B 184 0.89 -67.02 REMARK 500 LEU B 270 48.04 -96.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 402 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 77 O REMARK 620 2 HIS A 79 O 92.8 REMARK 620 3 ILE A 82 O 97.7 84.5 REMARK 620 4 THR A 84 OG1 96.8 159.6 111.9 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 79 O REMARK 620 2 ILE B 82 O 62.6 REMARK 620 3 GLU B 106 OE1 148.1 86.4 REMARK 620 4 HOH B 563 O 78.2 125.0 118.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2QV A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OBP RELATED DB: PDB REMARK 900 RELATED ID: 4OBQ RELATED DB: PDB DBREF 4OBO A 2 328 UNP O95819 M4K4_HUMAN 2 328 DBREF 4OBO B 2 328 UNP O95819 M4K4_HUMAN 2 328 SEQADV 4OBO GLY A 0 UNP O95819 EXPRESSION TAG SEQADV 4OBO SER A 1 UNP O95819 EXPRESSION TAG SEQADV 4OBO GLY A 329 UNP O95819 EXPRESSION TAG SEQADV 4OBO ASN A 330 UNP O95819 EXPRESSION TAG SEQADV 4OBO SER A 331 UNP O95819 EXPRESSION TAG SEQADV 4OBO GLY B 0 UNP O95819 EXPRESSION TAG SEQADV 4OBO SER B 1 UNP O95819 EXPRESSION TAG SEQADV 4OBO GLY B 329 UNP O95819 EXPRESSION TAG SEQADV 4OBO ASN B 330 UNP O95819 EXPRESSION TAG SEQADV 4OBO SER B 331 UNP O95819 EXPRESSION TAG SEQRES 1 A 332 GLY SER ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP SEQRES 2 A 332 ILE ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE SEQRES 3 A 332 GLU LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN SEQRES 4 A 332 VAL TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA SEQRES 5 A 332 ALA ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU SEQRES 6 A 332 GLU ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER SEQRES 7 A 332 HIS HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE SEQRES 8 A 332 LYS LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU SEQRES 9 A 332 VAL MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU SEQRES 10 A 332 VAL LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP SEQRES 11 A 332 ILE ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA SEQRES 12 A 332 HIS LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS SEQRES 13 A 332 GLY GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS SEQRES 14 A 332 LEU VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR SEQRES 15 A 332 VAL GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP SEQRES 16 A 332 MET ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP SEQRES 17 A 332 ALA THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY SEQRES 18 A 332 ILE THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU SEQRES 19 A 332 CYS ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO SEQRES 20 A 332 ARG ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER SEQRES 21 A 332 LYS LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS SEQRES 22 A 332 ASN TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS SEQRES 23 A 332 HIS PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL SEQRES 24 A 332 ARG ILE GLN LEU LYS ASP HIS ILE ASP ARG THR ARG LYS SEQRES 25 A 332 LYS ARG GLY GLU LYS ASP GLU THR GLU TYR GLU TYR SER SEQRES 26 A 332 GLY SER GLU GLU GLY ASN SER SEQRES 1 B 332 GLY SER ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP SEQRES 2 B 332 ILE ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE SEQRES 3 B 332 GLU LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN SEQRES 4 B 332 VAL TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA SEQRES 5 B 332 ALA ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU SEQRES 6 B 332 GLU ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER SEQRES 7 B 332 HIS HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE SEQRES 8 B 332 LYS LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU SEQRES 9 B 332 VAL MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU SEQRES 10 B 332 VAL LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP SEQRES 11 B 332 ILE ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA SEQRES 12 B 332 HIS LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS SEQRES 13 B 332 GLY GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS SEQRES 14 B 332 LEU VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR SEQRES 15 B 332 VAL GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP SEQRES 16 B 332 MET ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP SEQRES 17 B 332 ALA THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY SEQRES 18 B 332 ILE THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU SEQRES 19 B 332 CYS ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO SEQRES 20 B 332 ARG ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER SEQRES 21 B 332 LYS LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS SEQRES 22 B 332 ASN TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS SEQRES 23 B 332 HIS PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL SEQRES 24 B 332 ARG ILE GLN LEU LYS ASP HIS ILE ASP ARG THR ARG LYS SEQRES 25 B 332 LYS ARG GLY GLU LYS ASP GLU THR GLU TYR GLU TYR SER SEQRES 26 B 332 GLY SER GLU GLU GLY ASN SER HET MES A 401 12 HET NA A 402 1 HET 2QV A 403 18 HET NA B 401 1 HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM NA SODIUM ION HETNAM 2QV 6-(3-CHLOROPHENYL)QUINAZOLIN-4-AMINE FORMUL 3 MES C6 H13 N O4 S FORMUL 4 NA 2(NA 1+) FORMUL 5 2QV C14 H10 CL N3 FORMUL 7 HOH *230(H2 O) HELIX 1 1 ILE A 66 HIS A 78 1 13 HELIX 2 2 SER A 112 ASN A 119 1 8 HELIX 3 3 LYS A 126 HIS A 147 1 22 HELIX 4 4 LYS A 155 GLN A 157 5 3 HELIX 5 5 ALA A 196 ILE A 200 5 5 HELIX 6 6 ASP A 211 GLY A 229 1 19 HELIX 7 7 HIS A 237 ASN A 248 1 12 HELIX 8 8 SER A 259 LEU A 270 1 12 HELIX 9 9 ASN A 273 ARG A 277 5 5 HELIX 10 10 SER A 279 LYS A 285 1 7 HELIX 11 11 HIS A 286 ASP A 291 1 6 HELIX 12 12 ASN A 294 THR A 309 1 16 HELIX 13 13 THR B 59 LEU B 73 1 15 HELIX 14 14 SER B 112 ASN B 119 1 8 HELIX 15 15 LYS B 126 HIS B 147 1 22 HELIX 16 16 GLN B 177 VAL B 182 1 6 HELIX 17 17 ALA B 196 ILE B 200 5 5 HELIX 18 18 TYR B 212 GLY B 229 1 18 HELIX 19 19 HIS B 237 ASN B 248 1 12 HELIX 20 20 SER B 259 LEU B 270 1 12 HELIX 21 21 ASN B 273 ARG B 277 5 5 HELIX 22 22 SER B 279 LYS B 285 1 7 HELIX 23 23 HIS B 286 ASP B 291 1 6 HELIX 24 24 ASN B 294 LYS B 311 1 18 SHEET 1 A 5 PHE A 25 VAL A 31 0 SHEET 2 A 5 VAL A 39 HIS A 44 -1 O LYS A 41 N GLU A 29 SHEET 3 A 5 LEU A 50 VAL A 58 -1 O ALA A 51 N GLY A 42 SHEET 4 A 5 ASP A 99 GLU A 106 -1 O LEU A 101 N MET A 56 SHEET 5 A 5 TYR A 85 LYS A 91 -1 N TYR A 86 O VAL A 104 SHEET 1 B 2 VAL A 159 LEU A 161 0 SHEET 2 B 2 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 C 5 PHE B 25 LEU B 27 0 SHEET 2 C 5 GLN B 38 HIS B 44 -1 O ARG B 43 N GLU B 26 SHEET 3 C 5 LEU B 50 VAL B 58 -1 O ILE B 53 N TYR B 40 SHEET 4 C 5 ASP B 99 GLU B 106 -1 O LEU B 101 N MET B 56 SHEET 5 C 5 TYR B 85 LYS B 91 -1 N TYR B 86 O VAL B 104 SHEET 1 D 2 VAL B 159 LEU B 161 0 SHEET 2 D 2 VAL B 167 LEU B 169 -1 O LYS B 168 N LEU B 160 LINK O SER A 77 NA NA A 402 1555 1555 2.26 LINK O HIS A 79 NA NA A 402 1555 1555 2.36 LINK O ILE A 82 NA NA A 402 1555 1555 2.31 LINK OG1 THR A 84 NA NA A 402 1555 1555 2.49 LINK O HIS B 79 NA NA B 401 1555 1555 2.97 LINK O ILE B 82 NA NA B 401 1555 1555 2.74 LINK OE1 GLU B 106 NA NA B 401 1555 1555 2.79 LINK NA NA B 401 O HOH B 563 1555 1555 2.51 CISPEP 1 VAL A 31 GLY A 32 0 -3.58 SITE 1 AC1 11 MET A 275 GLN A 276 ARG A 277 PRO A 278 SITE 2 AC1 11 GLN A 282 ASP A 307 HOH A 507 HOH A 540 SITE 3 AC1 11 HOH A 557 MET B 275 GLN B 276 SITE 1 AC2 4 SER A 77 HIS A 79 ILE A 82 THR A 84 SITE 1 AC3 12 VAL A 31 TYR A 36 VAL A 39 ALA A 52 SITE 2 AC3 12 LYS A 54 MET A 105 GLU A 106 PHE A 107 SITE 3 AC3 12 CYS A 108 LEU A 160 VAL A 170 ASP A 171 SITE 1 AC4 6 HIS B 79 ILE B 82 THR B 84 GLU B 106 SITE 2 AC4 6 LYS B 168 HOH B 563 CRYST1 80.000 81.651 93.296 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012500 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012247 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010719 0.00000